Publications
Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international).
Purayil S, Thalappil S, Al-Nesf M, Kocaturk E.. Qatar Med J. 2022 Apr 4;2022(2):2. doi: 10.5339/qmj.2022.fqac.2. PMID: 35968517; PMCID: PMC9340567.
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
Kocatürk, E., Salameh, P., Sarac, E. et. al: The Journal of Allergy and Clinical Immunology. Published:August 11, 2023DOI:https://doi.org/10.1016/j.jaci.2023.07.019
Adrenaline autoinjector is underprescribed in typical cold urticaria patients.
Bizjak M, Košnik M, Dinevski D, Thomsen SF, et al. Allergy. 2022 Jul;77(7):2224-2229. doi: 10.1111/all.15274. Epub 2022 Mar 14. PMID: 35258111.
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study.
Bizjak M, Košnik M, Dinevski D, Thomsen SF, et. al. Allergy. 2021 Dec 4. doi: 10.1111/all.15194. Epub ahead of print.
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study.
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse … Read more
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study.
Maurer M, Weller K, Magerl M, et. al. World Allergy Organ J. 2020 Oct 30;13(11):100475. doi: 10.1016/j.waojou.2020.100475. PMID: 33204387; PMCID: PMC7606865.
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis.
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse … Read more